Testing effectiveness (Phase 2)Ended earlyNCT05037188
What this trial is testing
Clinical Study of the Safety and Immunogenicity of a Recombinant Viral Vector AAV5 (Adeno-Associated Virus Type 5 )-RBD (Receptor Binding Domain)-S Vaccine for the Prevention of Coronavirus Infection (COVID-19)
Who this might be right for
Coronavirus InfectionCOVID-19
Biocad 50